CVS Caremark Corporation announced the appointment of David M. Denton to the new role of Executive Vice President and Chief Financial Officer, effective January 1, 2010. Denton will succeed David Rickard who announced in February of this year his intention to retire as CFO. Denton, currently CVS Caremark's SVP, Controller and Chief Accounting Officer, brings nearly twenty years of financial management experience with a focus on the health care and retail drug sectors to his new position. Since joining the company in 1999, he has assumed positions of increasing responsibility including senior finance positions within CVS/pharmacy and CVS Caremark and role of Chief Financial Officer for PharmaCare. Replacing Denton in his current role of Controller and Chief Accounting Officer is Laird Daniels. Daniels, who joined CVS Caremark in 1997, was most recently Vice President of Finance and Retail Controller for CVS/pharmacy.

CVS Caremark Corporation reported unaudited consolidated earnings results for the third quarter and nine months ended September 30, 2009. For the quarter, net revenues increased $3.8 billion to $24.6 billion, up from $20.9 billion during the third quarter of 2008. Net revenues were positively impacted by one more reporting day during the third quarter of 2009 compared to the third quarter of 2008. Income from continuing operations increased 25.0% to $1.0 billion, compared with income from continuing operations of $818.8 million during the third quarter of 2008. Adjusted earnings per share from continuing operations, which excludes $108.0 million of intangible asset amortization related to acquisition activity, for the third quarter were $0.76 (including income tax benefit), compared with $0.60 in the third quarter of 2008. GAAP earnings per diluted share from continuing operations were $0.71 (including the $0.11 per diluted share income tax benefit), compared with $0.56 in the third quarter of 2008. Operating profit was $1,565.9 million and income from continuing operations before income tax provision was $1,443.1 million compared to operating profit of $1,466.2 million and income from continuing operations before income tax provision of $1,353.5 million for the same period last year. For the nine months, income from continuing operations increased 11.1% to $2.7 billion, compared with income from continuing operations of $2.4 billion during the nine months ended September 27, 2008. Adjusted earnings per share from continuing operations, which excludes $322.8 million of intangible asset amortization related to acquisition activity, were $1.96 (including income tax benefit), compared with $1.75 in the nine months ended September 27, 2008. GAAP earnings per diluted share from continuing operations were $1.82 (including income tax benefit), compared with $1.63 in the nine months ended September 27, 2008. Operating profit was $4,542.9 million and income from continuing operations before income tax provision was $4,150.1 million compared to operating profit of $4,314.4 million and income from continuing operations before income tax provision of $3,956.1 million for the same period last year. Net revenues were $72,906.9 million compared to $63,329.7 million for the same period last year. Net cash provided by operating activities was $2,230.6 million compared to $2,178.3 million for the same period last year. Additions to property and equipment was $1,752.5 million compared to $1,483.2 million for the same period last year.

CVS Caremark Corporation expected to Report Fiscal Year 2010 Results on February 1, 2010. This event was calculated by Capital IQ (Created on November 5, 2009).